{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:25:12Z","timestamp":1794349512169,"version":"4.9.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["202402130501006"],"award-info":[{"award-number":["202402130501006"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.isci.2026.117578","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:54:28Z","timestamp":1789746868000},"page":"117578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic reprogramming in diabetic panvascular disease: Molecular mechanism and therapeutic strategies"],"prefix":"10.1016","volume":"29","author":[{"given":"Yajing","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117578_bib1","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1093\/eurheartj\/ehac448","article-title":"Panvascular medicine: an emerging discipline focusing on atherosclerotic diseases","volume":"43","author":"Zhou","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2026.117578_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117578_bib3","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1038\/s41380-023-02066-3","article-title":"Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics","volume":"28","author":"Batista-Brito","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.isci.2026.117578_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2026.117578_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","article-title":"Diabetic peripheral neuropathy: current perspective and future directions","volume":"80","author":"Singh","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117578_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315088","article-title":"The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117578_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cbi.2014.10.007","article-title":"Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells","volume":"234","author":"Chang","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2026.117578_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2337\/diab.38.7.839","article-title":"Effects of sorbinil on glomerular structure and function in long-term- diabetic rats","volume":"38","author":"Mauer","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2026.117578_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","article-title":"Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes","volume":"52","author":"Cortese","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.117578_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.2052","article-title":"Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cel l apoptosis and diabetic retinopathy","volume":"15","author":"Geraldes","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117578_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.7150\/thno.63441","article-title":"METTL3-mediated N6-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication","volume":"12","author":"Suo","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117578_bib12","article-title":"Targeting single-cell multiomics-identified vascular impairment: Panax notoginseng extracellular vesicles-loaded adhesive QBK-2\/EVs promotes angiogenesis in diabetic wound healing","volume":"36","author":"Xia","year":"2026","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.isci.2026.117578_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/01.RES.0000137876.28454.64","article-title":"Protein glycation: a firm link to endothelial cell dysfunction","volume":"95","author":"Wautier","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2026.117578_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70396","article-title":"Free Radicals in Health and Disease","volume":"6","author":"Dai","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.117578_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41419-021-03750-4","article-title":"Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117578_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70018","article-title":"Potential mechanisms of metabolic reprogramming induced by ischemia-reperfusion injury in diabetic myocardium","volume":"16","author":"Ma","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.isci.2026.117578_bib17","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1042\/CS20180702","article-title":"Ectopic lipid accumulation: potential role in tubular injury and inflammation in diabetic kidney disease","volume":"132","author":"Yang","year":"2018","journal-title":"Clin. Sci."},{"key":"10.1016\/j.isci.2026.117578_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.117578_bib19","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1093\/eurheartj\/ehaa207","article-title":"Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier","volume":"41","author":"Liao","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2026.117578_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2362.2011.02475.x","article-title":"Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors","volume":"41","author":"Bernal-Lopez","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.isci.2026.117578_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ph19060868","article-title":"The Dual Role of Interleukin-6 in the Pathophysiology of Skeletal Muscle: Mechanisms, Challenges, and Therapeutic Prospects","volume":"19","author":"Wang","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.117578_bib22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.2013.276305","article-title":"Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes","volume":"310","author":"Qi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2026.117578_bib23","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2337\/db19-0145","article-title":"Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes","volume":"68","author":"Mathew","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2026.117578_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/333664a0","article-title":"Vascular endothelial cells synthesize nitric oxide from L-arginine","volume":"333","author":"Palmer","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117578_bib25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/CIRCULATIONAHA.120.049606","article-title":"Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure","volume":"144","author":"Leo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.117578_bib26","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2147\/IJN.S363168","article-title":"A Ternary Synergistic eNOS Gene Delivery System Based on Calcium Ion and L-Arginine for Accelerating Angiogenesis by Maximizing NO Production","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.isci.2026.117578_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/joim.12461","article-title":"Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels","volume":"279","author":"Kovamees","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.isci.2026.117578_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","article-title":"Serine and glycine metabolism in cancer","volume":"39","author":"Amelio","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2026.117578_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.nutr.012809.104810","article-title":"Compartmentalization of Mammalian folate-mediated one-carbon metabolism","volume":"30","author":"Tibbetts","year":"2010","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.isci.2026.117578_bib30","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2019.06.039","article-title":"One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages","volume":"75","author":"Yu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.117578_bib31","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3390\/ijms26073016","article-title":"Metabolic and Mitochondrial Dysregulations in Diabetic Cardiac Complications","volume":"26","author":"Tashkandi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117578_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117578_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12986-020-00486-4","article-title":"Endogenous asymmetric dimethylarginine accumulation contributes to the suppression of myocardial mitochondrial biogenesis in type 2 diabetic rats","volume":"17","author":"Xiong","year":"2020","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.isci.2026.117578_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.117578_bib35","doi-asserted-by":"crossref","first-page":"C749","DOI":"10.1152\/ajpcell.00346.2016","article-title":"ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria i n VEGF signaling and angiogenesis","volume":"312","author":"Kim","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.isci.2026.117578_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117999","article-title":"Network of cell death in myocardial ischemia-reperfusion injury: mechanisms and targeted therapeutic strategies","volume":"250","author":"Qi","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116799","article-title":"Endoplasmic reticulum stress and unfolded protein response: Roles in skeletal muscle atrophy","volume":"234","author":"Ji","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.isci.2026.117578_bib39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/dbi20-0030","article-title":"Epigenetic Mechanisms in Diabetic Vascular Complications and Metabolic Memory: The 2020 Edwin Bierman Award Lecture","volume":"70","author":"Natarajan","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2026.117578_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154308","article-title":"Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios","volume":"110","author":"Prattichizzo","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2026.117578_bib41","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/ehf2.12789","article-title":"Diabetes mellitus exacerbates post-myocardial infarction heart failure by reducing sarcolipin promoter methylation","volume":"7","author":"Liu","year":"2020","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.isci.2026.117578_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00125-020-05333-y","article-title":"Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats","volume":"64","author":"Jiang","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2026.117578_bib43","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/bph.14665","article-title":"Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach","volume":"176","author":"Platania","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106135","article-title":"Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications","volume":"178","author":"Xu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117578_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","article-title":"Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes","volume":"63","author":"Fan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2026.117578_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12967-021-03030-x","article-title":"Urinary small extracellular vesicles derived CCL21 mRNA as biomarker l inked with pathogenesis for diabetic nephropathy","volume":"19","author":"Feng","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.117578_bib47","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/s41467-022-33052-y","article-title":"Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast","volume":"13","author":"Geldhof","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117578_bib48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.arcmed.2020.05.018","article-title":"Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy","volume":"51","author":"Noor","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.isci.2026.117578_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2018.09.011","article-title":"Urinary kidney injury molecule-1 in renal disease","volume":"487","author":"Moresco","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2026.117578_bib50","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease","volume":"28","author":"Coca","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.117578_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ndt\/gfy314","article-title":"Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease","volume":"35","author":"Wu","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.isci.2026.117578_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.118031","article-title":"Mechanisms and therapeutic potential of the cGAS-STING signaling pathway in macrophage activation and polarization","volume":"250","author":"Liu","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.117854","article-title":"The cGAS-STING signaling pathway: A central regulator and novel therapeutic target in skeletal muscle pathophysiology","volume":"248","author":"Jiang","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117589","article-title":"Dual role of macrophages in skeletal muscle atrophy: Mechanisms and therapeutic strategies","volume":"244","author":"Shang","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib55","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117578_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.117578_bib57","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s12035-018-1195-5","article-title":"Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models","volume":"56","author":"Rom","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2026.117578_bib58","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/s41598-020-64349-x","article-title":"Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles","volume":"10","author":"Rom","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117578_bib59","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002247RR","article-title":"Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4\/Akt\/mTOR pathway","volume":"35","author":"Cui","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2026.117578_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12974-019-1688-9","article-title":"TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus","volume":"17","author":"Zhang","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.117578_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.118218","article-title":"The central role of endoplasmic reticulum stress in Parkinson\u2019s diseas e and targeted therapeutic strategies","volume":"252","author":"Chen","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2026.117578_bib62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/dc21-1124","article-title":"Prediction of Major Adverse Cardiovascular Events From Retinal, Clinic al, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort Study","volume":"45","author":"Mordi","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.117578_bib63","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.kint.2021.04.036","article-title":"Receptor activator of NF-\u03baB mediates podocyte injury in diabetic nephropathy","volume":"100","author":"Ke","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117578_bib64","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.kint.2018.09.019","article-title":"Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes","volume":"95","author":"Chauhan","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117578_bib65","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/dc20-0892","article-title":"Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study","volume":"43","author":"Samaras","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.117578_bib66","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/WNL.0000000000004586","article-title":"Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u226565 years with diabetes","volume":"89","author":"Orkaby","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.isci.2026.117578_bib67","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-016-0408-3","article-title":"Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice","volume":"15","author":"Yu","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.isci.2026.117578_bib68","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2026.117578_bib70","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib71","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171459","article-title":"Specific PKC \u03b2II inhibitor: one stone two birds in the treatment of di abetic foot ulcers","volume":"38","author":"Das","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.isci.2026.117578_bib72","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME\u00ae tri al","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2026.117578_bib73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib75","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib76","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib77","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.117578_bib78","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","article-title":"A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice","volume":"94","author":"Zhang","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2026.117578_bib79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib80","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.117578_bib81","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-019-1638-6","article-title":"The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke","volume":"16","author":"Shan","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.isci.2026.117578_bib82","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/hc3801.097806","article-title":"Improved arterial compliance by a novel advanced glycation end-product crosslink breaker","volume":"104","author":"Kass","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2026.117578_bib83","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S2213-8587(17)30317-0","article-title":"Effects on the incidence of cardiovascular events of the addition of p ioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial","volume":"5","author":"Vaccaro","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.isci.2026.117578_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/dom.12608","article-title":"Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes","volume":"18","author":"Erdmann","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2026.117578_bib85","first-page":"e16","article-title":"Correction to Lancet Diabetes Endocrinol 2018; 6:627-636","volume":"6","author":"Zhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.isci.2026.117578_bib86","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/dc20-2684","article-title":"The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b\/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes","volume":"44","author":"Klein","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.117578_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166238","article-title":"Nuclear factor of activated T-cells (NFAT) regulation of IL-1\u03b2-induced retinal vascular inflammation","volume":"1867","author":"Giblin","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.isci.2026.117578_bib88","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: result s from a Phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.isci.2026.117578_bib89","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117578_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.16803","article-title":"Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model","volume":"7","author":"Guo","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117578_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIOR ITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.isci.2026.117578_bib92","doi-asserted-by":"crossref","first-page":"H201","DOI":"10.1152\/ajpheart.00201.2016","article-title":"Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases","volume":"312","author":"Cabrera DeBuc","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.isci.2026.117578_bib93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fphys.2014.00175","article-title":"Mitochondria, endothelial cell function, and vascular diseases","volume":"5","author":"Tang","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2026.117578_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105912","article-title":"Management of inflammation in cardiovascular diseases","volume":"173","author":"Goswami","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.117578_bib95","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117578_bib96","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41467-022-29060-7","article-title":"Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226029573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:34:24Z","timestamp":1794346464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226029573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2589004226029573"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117578","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in diabetic panvascular disease: Molecular mechanism and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117578"}}